Cardiawave Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $2.45M

  • Investors
  • 17

Cardiawave General Information

Description

Developer of a non-invasive ultrasonic medical device designed to treat heart valve diseases. The company's device is real-time image-guided that uses ultrasounds to treat heart valve disease, particularly calcified aortic stenosis with no thermal injury, enabling clinicians to treat patients quickly, resulting in a higher likelihood of successful treatment.

Contact Information

Website
www.cardiawave.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
  • 3-5 rue Jules Guesde
  • Bat B
  • 92300 Levallois-Perret
  • France
+33 01 00 00 00 00

Cardiawave Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiawave Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 13-Sep-2022 $2.45M 000.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series B) 15-Oct-2020 000.00 000.00 000.00 Completed Clinical Trials - General
6. Early Stage VC (Series A) 27-Sep-2018 00.000 00.00 Completed Clinical Trials - General
5. Grant 15-Jun-2018 00.000 00.000 Completed Clinical Trials - General
4. Early Stage VC 06-Mar-2017 00.000 00.000 00.000 Completed Clinical Trials - General
3. Early Stage VC 29-Dec-2015 00.000 00.000 00.000 Completed Clinical Trials - General
2. Accelerator/Incubator 05-May-2015 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Cardiawave’s complete valuation and funding history, request access »

Cardiawave Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
ABSA-R2016 00,000 00.000000 000.00 000.00 00 000.00 00.000
ABSA-R2018 55,447 $1.002778 $86.24 $86.24 1x $86.24 21.92%
ABSA-R2015 47,895 $1.002778 $51.89 $51.89 1x $51.89 18.93%
To view Cardiawave’s complete cap table history, request access »

Cardiawave Patents

  • 13

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Cardiawave Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3196290-A1 Process for testing the accuracy and the performance of an ultrasound transducer Pending 23-Oct-2020 00000000
EP-3988167-A1 Process for testing the accuracy and the performance of an ultrasound transducer Pending 23-Oct-2020 00000000 0
EP-4232145-A1 Process for testing the accuracy and the performance of an ultrasound transducer Pending 23-Oct-2020 00000000
FR-3072577-B1 Apparatus for treating vascular thrombosis by ultrasound Active 23-Oct-2017 00000000
US-11633199-B2 Apparatus for treating vascular thrombosis by ultrasounds Active 23-Oct-2017 A61B17/22012 00
To view Cardiawave’s complete patent history, request access »

Cardiawave Executive Team (7)

Name Title Board Seat Contact Info
Benjamin Bertrand Co-Founder, Chief Executive Officer, President, Managing Director & Chairman
Maurice Delplanque Chief Operative Officer
Emmanuel Messas Co-Founder & Member of Scientific Advisory Board
Mathias Fink Ph.D Co-Founder & Member of Scientific Advisory Board
Michael Tanter Ph.D Co-Founder & Member of Scientific Advisory Board
You’re viewing 5 of 7 executive team members. Get the full list »

Cardiawave Board Members (8)

Name Representing Role Since
Armelle Graciet Self Board Member 000 0000
Benjamin Bertrand Cardiawave Co-Founder, Chief Executive Officer, President, Managing Director & Chairman 000 0000
Denis Gestin Self Board Member 000 0000
Emmanuel Blanc Self Board Member 000 0000
Francois Thomas Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Cardiawave Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardiawave Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angel's Bay Invest Angel Group Minority 000 0000 000000 0
Bernard Kirsch Angel (individual) Minority 000 0000 000000 0
Geoffroy de Casteja Angel (individual) Minority 000 0000 000000 0
I-Source Gestion Corporation Minority 000 0000 000000 0
Laurin Hainy Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial